

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of fibrinolysis (GO:0051918) | 9.36624402 |
| 2 | regulation of fibrinolysis (GO:0051917) | 8.69862019 |
| 3 | cellular glucuronidation (GO:0052695) | 8.08386809 |
| 4 | glyoxylate metabolic process (GO:0046487) | 7.94341719 |
| 5 | fibrinolysis (GO:0042730) | 7.69921980 |
| 6 | uronic acid metabolic process (GO:0006063) | 7.69256504 |
| 7 | glucuronate metabolic process (GO:0019585) | 7.69256504 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 7.17508864 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.17508864 |
| 10 | epoxygenase P450 pathway (GO:0019373) | 6.87170527 |
| 11 | oxidative demethylation (GO:0070989) | 6.74166625 |
| 12 | urea metabolic process (GO:0019627) | 6.70184857 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.64668967 |
| 14 | L-phenylalanine metabolic process (GO:0006558) | 6.64668967 |
| 15 | fat-soluble vitamin biosynthetic process (GO:0042362) | 6.64049091 |
| 16 | omega-hydroxylase P450 pathway (GO:0097267) | 6.56679021 |
| 17 | phenylpropanoid metabolic process (GO:0009698) | 6.41763326 |
| 18 | bile acid biosynthetic process (GO:0006699) | 6.39436303 |
| 19 | negative regulation of sterol transport (GO:0032372) | 6.18675282 |
| 20 | negative regulation of cholesterol transport (GO:0032375) | 6.18675282 |
| 21 | nitrogen cycle metabolic process (GO:0071941) | 6.08725823 |
| 22 | drug metabolic process (GO:0017144) | 6.08268384 |
| 23 | daunorubicin metabolic process (GO:0044597) | 6.06297954 |
| 24 | polyketide metabolic process (GO:0030638) | 6.06297954 |
| 25 | doxorubicin metabolic process (GO:0044598) | 6.06297954 |
| 26 | bile acid metabolic process (GO:0008206) | 5.80819450 |
| 27 | amino-acid betaine metabolic process (GO:0006577) | 5.67888995 |
| 28 | protein carboxylation (GO:0018214) | 5.67697468 |
| 29 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.67697468 |
| 30 | aromatic amino acid family catabolic process (GO:0009074) | 5.61730891 |
| 31 | alkaloid metabolic process (GO:0009820) | 5.52458799 |
| 32 | blood coagulation, intrinsic pathway (GO:0007597) | 5.46009379 |
| 33 | bile acid and bile salt transport (GO:0015721) | 5.42434404 |
| 34 | regulation of plasminogen activation (GO:0010755) | 5.42346842 |
| 35 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.38575215 |
| 36 | glycine metabolic process (GO:0006544) | 5.33765474 |
| 37 | serine family amino acid catabolic process (GO:0009071) | 5.32416106 |
| 38 | negative regulation of hemostasis (GO:1900047) | 5.27215120 |
| 39 | negative regulation of blood coagulation (GO:0030195) | 5.27215120 |
| 40 | regulation of protein activation cascade (GO:2000257) | 5.22792142 |
| 41 | urea cycle (GO:0000050) | 5.16804604 |
| 42 | ethanol oxidation (GO:0006069) | 5.08213942 |
| 43 | S-adenosylmethionine metabolic process (GO:0046500) | 4.96129860 |
| 44 | regulation of triglyceride catabolic process (GO:0010896) | 4.87741830 |
| 45 | negative regulation of coagulation (GO:0050819) | 4.79804343 |
| 46 | regulation of complement activation (GO:0030449) | 4.73591890 |
| 47 | phospholipid efflux (GO:0033700) | 4.71405610 |
| 48 | intestinal cholesterol absorption (GO:0030299) | 4.69382707 |
| 49 | triglyceride homeostasis (GO:0070328) | 4.68118341 |
| 50 | acylglycerol homeostasis (GO:0055090) | 4.68118341 |
| 51 | negative regulation of wound healing (GO:0061045) | 4.64829379 |
| 52 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 4.62566670 |
| 53 | heme transport (GO:0015886) | 4.59311843 |
| 54 | primary alcohol catabolic process (GO:0034310) | 4.50185612 |
| 55 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.42932349 |
| 56 | L-methionine salvage (GO:0071267) | 4.41014049 |
| 57 | L-methionine biosynthetic process (GO:0071265) | 4.41014049 |
| 58 | amino acid salvage (GO:0043102) | 4.41014049 |
| 59 | alpha-linolenic acid metabolic process (GO:0036109) | 4.39627735 |
| 60 | positive regulation of blood coagulation (GO:0030194) | 4.38963377 |
| 61 | positive regulation of hemostasis (GO:1900048) | 4.38963377 |
| 62 | complement activation, alternative pathway (GO:0006957) | 4.38252104 |
| 63 | hormone catabolic process (GO:0042447) | 4.33973330 |
| 64 | negative regulation of lipase activity (GO:0060192) | 4.32710385 |
| 65 | tryptophan catabolic process (GO:0006569) | 4.23261581 |
| 66 | indole-containing compound catabolic process (GO:0042436) | 4.23261581 |
| 67 | indolalkylamine catabolic process (GO:0046218) | 4.23261581 |
| 68 | response to mercury ion (GO:0046689) | 4.22995188 |
| 69 | ethanol metabolic process (GO:0006067) | 4.11183785 |
| 70 | serine family amino acid metabolic process (GO:0009069) | 4.08875508 |
| 71 | positive regulation of coagulation (GO:0050820) | 4.07807289 |
| 72 | steroid catabolic process (GO:0006706) | 4.07692725 |
| 73 | regulation of lipoprotein particle clearance (GO:0010984) | 4.01208385 |
| 74 | arginine metabolic process (GO:0006525) | 4.00898261 |
| 75 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.00498224 |
| 76 | vitamin biosynthetic process (GO:0009110) | 3.99183986 |
| 77 | flavonoid metabolic process (GO:0009812) | 3.96777825 |
| 78 | tyrosine metabolic process (GO:0006570) | 3.93565703 |
| 79 | xenobiotic metabolic process (GO:0006805) | 3.88119462 |
| 80 | drug transmembrane transport (GO:0006855) | 3.86130625 |
| 81 | high-density lipoprotein particle remodeling (GO:0034375) | 3.84474546 |
| 82 | regulation of response to tumor cell (GO:0002834) | 3.76494689 |
| 83 | positive regulation of response to tumor cell (GO:0002836) | 3.76494689 |
| 84 | positive regulation of immune response to tumor cell (GO:0002839) | 3.76494689 |
| 85 | regulation of immune response to tumor cell (GO:0002837) | 3.76494689 |
| 86 | cholesterol efflux (GO:0033344) | 3.72252491 |
| 87 | aromatic amino acid family metabolic process (GO:0009072) | 3.62872710 |
| 88 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.59468649 |
| 89 | androgen metabolic process (GO:0008209) | 3.55550573 |
| 90 | negative regulation of fatty acid metabolic process (GO:0045922) | 3.49989298 |
| 91 | plasma lipoprotein particle remodeling (GO:0034369) | 3.48565683 |
| 92 | protein-lipid complex remodeling (GO:0034368) | 3.48565683 |
| 93 | macromolecular complex remodeling (GO:0034367) | 3.48565683 |
| 94 | tryptophan metabolic process (GO:0006568) | 3.45300544 |
| 95 | acute-phase response (GO:0006953) | 3.43404104 |
| 96 | sodium-independent organic anion transport (GO:0043252) | 3.42476251 |
| 97 | carnitine metabolic process (GO:0009437) | 3.40898676 |
| 98 | plasma lipoprotein particle clearance (GO:0034381) | 3.39271364 |
| 99 | exogenous drug catabolic process (GO:0042738) | 12.2107140 |
| 100 | drug catabolic process (GO:0042737) | 10.6822929 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.04963579 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.45444124 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.97253356 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.68509476 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.10137344 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.82614564 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.71087832 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.37443927 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.79466876 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.35431287 |
| 11 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.27371578 |
| 12 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.21849610 |
| 13 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.16954784 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.9871288 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.72933121 |
| 16 | * ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.53101282 |
| 17 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.42664582 |
| 18 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.38273291 |
| 19 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.37026561 |
| 20 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.34209579 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.28458132 |
| 22 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.21410220 |
| 23 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.19255796 |
| 24 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.15546600 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.11848707 |
| 26 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.11071713 |
| 27 | CBP_21632823_ChIP-Seq_H3396_Human | 1.06219226 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.04792676 |
| 29 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.03068333 |
| 30 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02441074 |
| 31 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.02028563 |
| 32 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.01369743 |
| 33 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99101611 |
| 34 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98050383 |
| 35 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.97734236 |
| 36 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.96615670 |
| 37 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.94752918 |
| 38 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.94410145 |
| 39 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.88861151 |
| 40 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.85015706 |
| 41 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.84084535 |
| 42 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.84044199 |
| 43 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.82287807 |
| 44 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.80196130 |
| 45 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.80114180 |
| 46 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.78695547 |
| 47 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.78134606 |
| 48 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.76649823 |
| 49 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.76649823 |
| 50 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.76341041 |
| 51 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.75583928 |
| 52 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.74913273 |
| 53 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.73249136 |
| 54 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.72658750 |
| 55 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.70152978 |
| 56 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.69649931 |
| 57 | AR_20517297_ChIP-Seq_VCAP_Human | 0.69629796 |
| 58 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.68443412 |
| 59 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.66760813 |
| 60 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.65843873 |
| 61 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.65465597 |
| 62 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.65384223 |
| 63 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.65008378 |
| 64 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.64732301 |
| 65 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.63723895 |
| 66 | CJUN_26792858_Chip-Seq_BT549_Human | 0.62369176 |
| 67 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.60234180 |
| 68 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.60084286 |
| 69 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.59570142 |
| 70 | NFYA_21822215_ChIP-Seq_K562_Human | 0.59467857 |
| 71 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.58952454 |
| 72 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.58691622 |
| 73 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.58568618 |
| 74 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.58353198 |
| 75 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.57360349 |
| 76 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.56151609 |
| 77 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.55356821 |
| 78 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.54777485 |
| 79 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.54126287 |
| 80 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.54056982 |
| 81 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.53852288 |
| 82 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.53846123 |
| 83 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.53831674 |
| 84 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.53646650 |
| 85 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.53375064 |
| 86 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.53342438 |
| 87 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.52377255 |
| 88 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.52241656 |
| 89 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.51269837 |
| 90 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.51262700 |
| 91 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.50687982 |
| 92 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.49623005 |
| 93 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.49436517 |
| 94 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.49236528 |
| 95 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.49236528 |
| 96 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.49217132 |
| 97 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.48175512 |
| 98 | * RAC3_21632823_ChIP-Seq_H3396_Human | 0.48085383 |
| 99 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.47756235 |
| 100 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.47225747 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005365_abnormal_bile_salt | 6.19900782 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 6.00936662 |
| 3 | MP0008875_abnormal_xenobiotic_pharmacok | 5.33451243 |
| 4 | MP0005360_urolithiasis | 5.16352565 |
| 5 | MP0003195_calcinosis | 4.91906460 |
| 6 | MP0002138_abnormal_hepatobiliary_system | 4.26976815 |
| 7 | MP0003252_abnormal_bile_duct | 4.26241275 |
| 8 | MP0003868_abnormal_feces_composition | 3.74318019 |
| 9 | MP0001666_abnormal_nutrient_absorption | 3.59804800 |
| 10 | MP0009840_abnormal_foam_cell | 3.07907025 |
| 11 | MP0009697_abnormal_copulation | 2.68901977 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.51670758 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.25976821 |
| 14 | MP0002876_abnormal_thyroid_physiology | 2.14884672 |
| 15 | MP0005332_abnormal_amino_acid | 2.11379390 |
| 16 | MP0002139_abnormal_hepatobiliary_system | 11.3241026 |
| 17 | MP0000609_abnormal_liver_physiology | 1.79473862 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 1.60867293 |
| 19 | MP0001764_abnormal_homeostasis | 1.52542182 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 1.27984198 |
| 21 | MP0005319_abnormal_enzyme/_coenzyme | 1.21569377 |
| 22 | MP0005408_hypopigmentation | 1.21441623 |
| 23 | MP0009053_abnormal_anal_canal | 1.18709234 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.07584157 |
| 25 | MP0003656_abnormal_erythrocyte_physiolo | 1.01688277 |
| 26 | MP0005451_abnormal_body_composition | 0.99943771 |
| 27 | MP0004019_abnormal_vitamin_homeostasis | 0.97215955 |
| 28 | MP0009643_abnormal_urine_homeostasis | 0.92355405 |
| 29 | MP0003011_delayed_dark_adaptation | 0.89419455 |
| 30 | MP0001661_extended_life_span | 0.89236939 |
| 31 | MP0000598_abnormal_liver_morphology | 0.88156317 |
| 32 | MP0003186_abnormal_redox_activity | 0.87899599 |
| 33 | MP0005376_homeostasis/metabolism_phenot | 0.76558545 |
| 34 | MP0009642_abnormal_blood_homeostasis | 0.76378184 |
| 35 | MP0008469_abnormal_protein_level | 0.75706397 |
| 36 | MP0009763_increased_sensitivity_to | 0.72909113 |
| 37 | MP0001915_intracranial_hemorrhage | 0.71681168 |
| 38 | MP0003879_abnormal_hair_cell | 0.70321088 |
| 39 | MP0003638_abnormal_response/metabolism_ | 0.68115350 |
| 40 | MP0005395_other_phenotype | 0.67850797 |
| 41 | MP0005636_abnormal_mineral_homeostasis | 0.66861753 |
| 42 | MP0005187_abnormal_penis_morphology | 0.65913346 |
| 43 | MP0000604_amyloidosis | 0.64261581 |
| 44 | MP0005464_abnormal_platelet_physiology | 0.63165903 |
| 45 | MP0010368_abnormal_lymphatic_system | 0.62703316 |
| 46 | MP0006036_abnormal_mitochondrial_physio | 0.61803071 |
| 47 | MP0005023_abnormal_wound_healing | 0.60810740 |
| 48 | MP0002971_abnormal_brown_adipose | 0.59904800 |
| 49 | MP0003718_maternal_effect | 0.56560439 |
| 50 | MP0003690_abnormal_glial_cell | 0.54346365 |
| 51 | MP0002168_other_aberrant_phenotype | 0.52978180 |
| 52 | MP0003959_abnormal_lean_body | 0.52628750 |
| 53 | MP0005535_abnormal_body_temperature | 0.52140210 |
| 54 | MP0005266_abnormal_metabolism | 0.51767163 |
| 55 | MP0003300_gastrointestinal_ulcer | 0.51094920 |
| 56 | MP0009764_decreased_sensitivity_to | 0.48814799 |
| 57 | MP0008874_decreased_physiological_sensi | 0.46958043 |
| 58 | MP0005647_abnormal_sex_gland | 0.45976966 |
| 59 | MP0002132_abnormal_respiratory_system | 0.45917787 |
| 60 | MP0002078_abnormal_glucose_homeostasis | 0.45879023 |
| 61 | MP0003329_amyloid_beta_deposits | 0.45208037 |
| 62 | MP0005058_abnormal_lysosome_morphology | 0.43901790 |
| 63 | MP0008873_increased_physiological_sensi | 0.43609127 |
| 64 | MP0006035_abnormal_mitochondrial_morpho | 0.43382118 |
| 65 | MP0005670_abnormal_white_adipose | 0.41365346 |
| 66 | MP0005164_abnormal_response_to | 0.39394212 |
| 67 | MP0005334_abnormal_fat_pad | 0.37711040 |
| 68 | MP0004142_abnormal_muscle_tone | 0.37184055 |
| 69 | MP0000249_abnormal_blood_vessel | 0.36963387 |
| 70 | MP0004883_abnormal_blood_vessel | 0.35738297 |
| 71 | MP0001851_eye_inflammation | 0.30465863 |
| 72 | MP0005197_abnormal_uvea_morphology | 0.30331048 |
| 73 | MP0002282_abnormal_trachea_morphology | 0.29922282 |
| 74 | MP0002249_abnormal_larynx_morphology | 0.27851775 |
| 75 | MP0005084_abnormal_gallbladder_morpholo | 0.27266376 |
| 76 | MP0005448_abnormal_energy_balance | 0.27002403 |
| 77 | MP0009785_altered_susceptibility_to | 0.25881516 |
| 78 | MP0003075_altered_response_to | 0.24644178 |
| 79 | MP0001756_abnormal_urination | 0.23106145 |
| 80 | MP0002928_abnormal_bile_duct | 0.22911287 |
| 81 | MP0003632_abnormal_nervous_system | 0.22820538 |
| 82 | MP0002136_abnormal_kidney_physiology | 0.22690194 |
| 83 | MP0000920_abnormal_myelination | 0.21800771 |
| 84 | MP0000467_abnormal_esophagus_morphology | 0.21712085 |
| 85 | MP0001881_abnormal_mammary_gland | 0.21211248 |
| 86 | MP0002970_abnormal_white_adipose | 0.20903882 |
| 87 | MP0009765_abnormal_xenobiotic_induced | 0.19982150 |
| 88 | MP0008872_abnormal_physiological_respon | 0.19794338 |
| 89 | MP0003953_abnormal_hormone_level | 0.18633572 |
| 90 | MP0003566_abnormal_cell_adhesion | 0.18480158 |
| 91 | MP0002090_abnormal_vision | 0.18451344 |
| 92 | MP0005166_decreased_susceptibility_to | 0.17681942 |
| 93 | MP0004130_abnormal_muscle_cell | 0.16472391 |
| 94 | MP0001845_abnormal_inflammatory_respons | 0.16051274 |
| 95 | MP0005220_abnormal_exocrine_pancreas | 0.15762449 |
| 96 | MP0009115_abnormal_fat_cell | 0.13619550 |
| 97 | MP0000003_abnormal_adipose_tissue | 0.13305575 |
| 98 | MP0005330_cardiomyopathy | 0.13083742 |
| 99 | MP0000858_altered_metastatic_potential | 0.12913650 |
| 100 | MP0005377_hearing/vestibular/ear_phenot | 0.12269238 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypobetalipoproteinemia (HP:0003563) | 8.63018175 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 8.43719667 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.93208554 |
| 4 | Conjugated hyperbilirubinemia (HP:0002908) | 6.80099009 |
| 5 | Complement deficiency (HP:0004431) | 5.81038105 |
| 6 | Hyperlipoproteinemia (HP:0010980) | 5.65469598 |
| 7 | Joint hemorrhage (HP:0005261) | 5.49136882 |
| 8 | Intrahepatic cholestasis (HP:0001406) | 5.44631793 |
| 9 | Abnormality of complement system (HP:0005339) | 4.96446465 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 4.93405623 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.84196146 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.67766521 |
| 13 | Xanthomatosis (HP:0000991) | 4.57962543 |
| 14 | Fat malabsorption (HP:0002630) | 4.52723608 |
| 15 | Rickets (HP:0002748) | 4.41581900 |
| 16 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.37592147 |
| 17 | Steatorrhea (HP:0002570) | 4.31514176 |
| 18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.09004975 |
| 19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.91235569 |
| 20 | Hyperglycinemia (HP:0002154) | 3.85904829 |
| 21 | Abnormality of the intrinsic pathway (HP:0010989) | 3.67560892 |
| 22 | Vascular calcification (HP:0004934) | 3.59946101 |
| 23 | Generalized aminoaciduria (HP:0002909) | 3.57879563 |
| 24 | Mitral stenosis (HP:0001718) | 3.47388971 |
| 25 | Hyperammonemia (HP:0001987) | 3.44536300 |
| 26 | Glomerulonephritis (HP:0000099) | 3.43114840 |
| 27 | Spontaneous abortion (HP:0005268) | 3.39920808 |
| 28 | Hyperglycinuria (HP:0003108) | 3.34668249 |
| 29 | Hemorrhage of the eye (HP:0011885) | 3.33667365 |
| 30 | Hypochromic microcytic anemia (HP:0004840) | 3.30156854 |
| 31 | Cardiovascular calcification (HP:0011915) | 3.19301555 |
| 32 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.14114491 |
| 33 | Abnormality of glycine metabolism (HP:0010895) | 3.14114491 |
| 34 | Bifid scrotum (HP:0000048) | 3.11734521 |
| 35 | Nephritis (HP:0000123) | 3.08985364 |
| 36 | Hypercholesterolemia (HP:0003124) | 3.02956904 |
| 37 | Abnormality of vitamin metabolism (HP:0100508) | 2.94597750 |
| 38 | Abnormality of serum amino acid levels (HP:0003112) | 2.88273863 |
| 39 | Delayed CNS myelination (HP:0002188) | 2.85250289 |
| 40 | Reduced antithrombin III activity (HP:0001976) | 2.81650373 |
| 41 | Osteomalacia (HP:0002749) | 2.77726082 |
| 42 | Hyperphosphaturia (HP:0003109) | 2.66933624 |
| 43 | Gingival bleeding (HP:0000225) | 2.65096777 |
| 44 | Glycosuria (HP:0003076) | 2.62153164 |
| 45 | Abnormality of urine glucose concentration (HP:0011016) | 2.62153164 |
| 46 | Hyperbilirubinemia (HP:0002904) | 2.58586980 |
| 47 | Hypochromic anemia (HP:0001931) | 2.55733705 |
| 48 | Abnormality of methionine metabolism (HP:0010901) | 2.53839699 |
| 49 | Epidermoid cyst (HP:0200040) | 2.48010019 |
| 50 | Purpura (HP:0000979) | 2.43478609 |
| 51 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.43176061 |
| 52 | Abnormality of the Achilles tendon (HP:0005109) | 2.40316624 |
| 53 | Abnormality of nucleobase metabolism (HP:0010932) | 2.39887275 |
| 54 | Irritability (HP:0000737) | 2.38950251 |
| 55 | Arthropathy (HP:0003040) | 2.34256962 |
| 56 | Metabolic acidosis (HP:0001942) | 2.24446322 |
| 57 | Hypophosphatemic rickets (HP:0004912) | 2.23132061 |
| 58 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.21642701 |
| 59 | Abnormal gallbladder physiology (HP:0012438) | 2.20471405 |
| 60 | Cholecystitis (HP:0001082) | 2.20471405 |
| 61 | Increased mean platelet volume (HP:0011877) | 2.20119272 |
| 62 | Hypoalphalipoproteinemia (HP:0003233) | 2.19620725 |
| 63 | Pulmonary embolism (HP:0002204) | 2.14499834 |
| 64 | Abnormal urine phosphate concentration (HP:0012599) | 2.14015617 |
| 65 | Poikilocytosis (HP:0004447) | 2.11678497 |
| 66 | Thrombophlebitis (HP:0004418) | 2.09325795 |
| 67 | Menorrhagia (HP:0000132) | 2.03174161 |
| 68 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 11.1221290 |
| 69 | Deep venous thrombosis (HP:0002625) | 10.2861947 |
| 70 | Myocardial infarction (HP:0001658) | 1.99538394 |
| 71 | Abnormal platelet volume (HP:0011876) | 1.99282177 |
| 72 | Cholelithiasis (HP:0001081) | 1.93932974 |
| 73 | Abnormal gallbladder morphology (HP:0012437) | 1.92967293 |
| 74 | Hydroxyprolinuria (HP:0003080) | 1.91863730 |
| 75 | Abnormality of proline metabolism (HP:0010907) | 1.91863730 |
| 76 | Retinal atrophy (HP:0001105) | 1.90028901 |
| 77 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.89776673 |
| 78 | Abnormal platelet function (HP:0011869) | 1.84243784 |
| 79 | Impaired platelet aggregation (HP:0003540) | 1.84243784 |
| 80 | Back pain (HP:0003418) | 1.83615178 |
| 81 | Fair hair (HP:0002286) | 1.83509255 |
| 82 | Hepatocellular carcinoma (HP:0001402) | 1.82042224 |
| 83 | Elevated alkaline phosphatase (HP:0003155) | 1.81891060 |
| 84 | Abnormal biliary tract physiology (HP:0012439) | 1.81740668 |
| 85 | Bile duct proliferation (HP:0001408) | 1.81740668 |
| 86 | Atrioventricular block (HP:0001678) | 1.81060853 |
| 87 | Proximal tubulopathy (HP:0000114) | 1.78791804 |
| 88 | Submucous cleft hard palate (HP:0000176) | 1.74052180 |
| 89 | Ketosis (HP:0001946) | 1.73686470 |
| 90 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.72615795 |
| 91 | Neonatal onset (HP:0003623) | 1.71769586 |
| 92 | Abnormal tarsal ossification (HP:0008369) | 1.71698894 |
| 93 | Hypoglycemic coma (HP:0001325) | 1.70988480 |
| 94 | Joint swelling (HP:0001386) | 1.70126231 |
| 95 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.70045655 |
| 96 | Acanthocytosis (HP:0001927) | 1.68386283 |
| 97 | Gangrene (HP:0100758) | 1.66524451 |
| 98 | Lethargy (HP:0001254) | 1.65594656 |
| 99 | Sensorimotor neuropathy (HP:0007141) | 1.62569093 |
| 100 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.60838748 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK1 | 4.43262048 |
| 2 | IRAK3 | 4.13521095 |
| 3 | ERN1 | 3.85000102 |
| 4 | MAP3K12 | 3.70097583 |
| 5 | MAP3K3 | 3.29441004 |
| 6 | PIK3CG | 3.12418339 |
| 7 | PRPF4B | 2.65318970 |
| 8 | FGFR4 | 2.51171098 |
| 9 | TYK2 | 2.41976481 |
| 10 | TBK1 | 2.21111060 |
| 11 | NTRK3 | 2.12247059 |
| 12 | ABL2 | 1.93816053 |
| 13 | PINK1 | 1.87468046 |
| 14 | PIK3CA | 1.87049811 |
| 15 | NEK9 | 1.85942912 |
| 16 | MYLK | 1.82028313 |
| 17 | PRKACG | 1.78387786 |
| 18 | MST1R | 1.67906649 |
| 19 | MAP3K2 | 1.63985519 |
| 20 | FGFR3 | 1.42527037 |
| 21 | MAP3K5 | 1.39726556 |
| 22 | MAP2K4 | 1.39178575 |
| 23 | EPHA3 | 1.37854512 |
| 24 | PRKCG | 1.37595058 |
| 25 | IGF1R | 1.37150333 |
| 26 | TRIB3 | 1.35916501 |
| 27 | TAOK2 | 1.31632845 |
| 28 | MAPK11 | 1.25424280 |
| 29 | BCR | 1.25306013 |
| 30 | MAP3K11 | 1.22795083 |
| 31 | ERBB4 | 1.21348872 |
| 32 | PRKAA2 | 1.20557416 |
| 33 | BCKDK | 1.20099631 |
| 34 | EIF2AK1 | 1.12961388 |
| 35 | MAP3K1 | 1.11691818 |
| 36 | KSR2 | 1.10527955 |
| 37 | SIK1 | 1.08844865 |
| 38 | JAK1 | 1.08190496 |
| 39 | JAK2 | 1.05226882 |
| 40 | MAP3K14 | 1.04177683 |
| 41 | PDPK1 | 1.03200469 |
| 42 | PRKCZ | 1.00950982 |
| 43 | MAPKAPK3 | 0.93073474 |
| 44 | EPHA4 | 0.85265588 |
| 45 | ZAP70 | 0.83484568 |
| 46 | MAP2K3 | 0.81965388 |
| 47 | SCYL2 | 0.80370210 |
| 48 | MAP3K6 | 0.77835116 |
| 49 | ACVR1B | 0.74494675 |
| 50 | NLK | 0.71754024 |
| 51 | ERBB2 | 0.71200538 |
| 52 | FRK | 0.70862143 |
| 53 | PRKG1 | 0.70647955 |
| 54 | PIM2 | 0.70010917 |
| 55 | RET | 0.69793617 |
| 56 | PRKACA | 0.68574265 |
| 57 | PRKAA1 | 0.67411108 |
| 58 | PTK6 | 0.67097246 |
| 59 | CSNK1D | 0.65356181 |
| 60 | TAOK1 | 0.65053187 |
| 61 | CAMKK2 | 0.63194915 |
| 62 | STK38L | 0.63129614 |
| 63 | FER | 0.63066359 |
| 64 | STK38 | 0.62358730 |
| 65 | PRKCB | 0.58964577 |
| 66 | EPHB1 | 0.57952541 |
| 67 | PDK1 | 0.57928713 |
| 68 | CDK12 | 0.57746756 |
| 69 | PRKCA | 0.56394349 |
| 70 | CAMK2G | 0.55419351 |
| 71 | ICK | 0.55085633 |
| 72 | TNK2 | 0.55071141 |
| 73 | CDK6 | 0.54755308 |
| 74 | STK16 | 0.51202993 |
| 75 | CHUK | 0.50552587 |
| 76 | TESK2 | 0.49027382 |
| 77 | DAPK2 | 0.48498929 |
| 78 | TAOK3 | 0.48358790 |
| 79 | LIMK1 | 0.48316689 |
| 80 | INSRR | 0.47705771 |
| 81 | ARAF | 0.44787392 |
| 82 | RPS6KA3 | 0.44733581 |
| 83 | MAP3K9 | 0.43236814 |
| 84 | SGK3 | 0.42562011 |
| 85 | GSK3A | 0.42085727 |
| 86 | SGK1 | 0.41884023 |
| 87 | DYRK1B | 0.40030951 |
| 88 | MUSK | 0.39469292 |
| 89 | MAPK4 | 0.37665478 |
| 90 | IKBKB | 0.36114539 |
| 91 | PBK | 0.35865181 |
| 92 | IKBKE | 0.35655483 |
| 93 | MAPK15 | 0.34687887 |
| 94 | MAP3K13 | 0.33344846 |
| 95 | RAF1 | 0.33115052 |
| 96 | DAPK3 | 0.31629032 |
| 97 | SRC | 0.31626876 |
| 98 | CASK | 0.31205360 |
| 99 | PAK3 | 0.29355607 |
| 100 | MET | 0.29138586 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 5.84588407 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.32499752 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.84242772 |
| 4 | Retinol metabolism_Homo sapiens_hsa00830 | 3.46345798 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.35514226 |
| 6 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.31351851 |
| 7 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 3.23053925 |
| 8 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 3.12352638 |
| 9 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 3.07537481 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.94089965 |
| 11 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.93269691 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.79650966 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.65492175 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.35090105 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.06735882 |
| 16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.04982641 |
| 17 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.04709191 |
| 18 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.00004228 |
| 19 | Bile secretion_Homo sapiens_hsa04976 | 1.97423999 |
| 20 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.93660030 |
| 21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.92998613 |
| 22 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.92923907 |
| 23 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.76505716 |
| 24 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.66072580 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.61589645 |
| 26 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.58905698 |
| 27 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.58619120 |
| 28 | Peroxisome_Homo sapiens_hsa04146 | 1.35480192 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.32553729 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.30608092 |
| 31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.30462367 |
| 32 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.29114966 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.10669867 |
| 34 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.08308388 |
| 35 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.07087011 |
| 36 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.06254842 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.05354191 |
| 38 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.05348688 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.96890825 |
| 40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.96664760 |
| 41 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.89128063 |
| 42 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.88189644 |
| 43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88021539 |
| 44 | Carbon metabolism_Homo sapiens_hsa01200 | 0.81660383 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.75852144 |
| 46 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.70694796 |
| 47 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.67295513 |
| 48 | Lysine degradation_Homo sapiens_hsa00310 | 0.66602368 |
| 49 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.63320402 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 0.61179490 |
| 51 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.57757072 |
| 52 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.55777408 |
| 53 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.54629501 |
| 54 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.50994563 |
| 55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.50578682 |
| 56 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.45714284 |
| 57 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.41054367 |
| 58 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40201471 |
| 59 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.39603106 |
| 60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.37041003 |
| 61 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.33046924 |
| 62 | Sulfur relay system_Homo sapiens_hsa04122 | 0.30764611 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.25491647 |
| 64 | Prion diseases_Homo sapiens_hsa05020 | 0.24087663 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.21305017 |
| 66 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.19620107 |
| 67 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.16877408 |
| 68 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.16557559 |
| 69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.16049840 |
| 70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.09455250 |
| 71 | Pertussis_Homo sapiens_hsa05133 | 0.09016514 |
| 72 | Insulin resistance_Homo sapiens_hsa04931 | 0.02168726 |
| 73 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.00518187 |
| 74 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2814921 |
| 75 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2705148 |
| 76 | Lysosome_Homo sapiens_hsa04142 | -0.2628336 |
| 77 | Amoebiasis_Homo sapiens_hsa05146 | -0.2475211 |
| 78 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2331307 |
| 79 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.2238347 |
| 80 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.2225653 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2219440 |
| 82 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2110209 |
| 83 | Hepatitis C_Homo sapiens_hsa05160 | -0.2071404 |
| 84 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1917000 |
| 85 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1697412 |
| 86 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | -0.1516451 |
| 87 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.1414086 |
| 88 | Mineral absorption_Homo sapiens_hsa04978 | -0.1368215 |
| 89 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1307541 |
| 90 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1281445 |
| 91 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1218769 |
| 92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.1166071 |
| 93 | Galactose metabolism_Homo sapiens_hsa00052 | -0.1156177 |
| 94 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0992428 |
| 95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | -0.0542123 |
| 96 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0337866 |
| 97 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | -0.0287089 |
| 98 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0279643 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0176409 |
| 100 | Folate biosynthesis_Homo sapiens_hsa00790 | -0.0084712 |

